179 related articles for article (PubMed ID: 25087462)
1. A monoclonal antibody-based immunoassay for measuring the potency of 2009 pandemic influenza H1N1 vaccines.
Schmeisser F; Vasudevan A; Soto J; Kumar A; Williams O; Weir JP
Influenza Other Respir Viruses; 2014 Sep; 8(5):587-95. PubMed ID: 25087462
[TBL] [Abstract][Full Text] [Related]
2. Determination of influenza B identity and potency in quadrivalent inactivated influenza vaccines using lineage-specific monoclonal antibodies.
Verma S; Soto J; Vasudevan A; Schmeisser F; Alvarado-Facundo E; Wang W; Weiss CD; Weir JP
PLoS One; 2017; 12(4):e0175733. PubMed ID: 28423025
[TBL] [Abstract][Full Text] [Related]
3. Potency determination of inactivated H7 influenza vaccines using monoclonal antibody-based ELISA and biolayer interferometry assays.
Vasudevan A; Woerner A; Schmeisser F; Verma S; Williams O; Weir JP
Influenza Other Respir Viruses; 2018 Mar; 12(2):250-258. PubMed ID: 29152878
[TBL] [Abstract][Full Text] [Related]
4. An alternative method for preparation of pandemic influenza strain-specific antibody for vaccine potency determination.
Schmeisser F; Vodeiko GM; Lugovtsev VY; Stout RR; Weir JP
Vaccine; 2010 Mar; 28(12):2442-9. PubMed ID: 20074687
[TBL] [Abstract][Full Text] [Related]
5. A novel approach for preparation of the antisera reagent for potency determination of inactivated H7N9 influenza vaccines.
Schmeisser F; Jing X; Joshi M; Vasudevan A; Soto J; Li X; Choudhary A; Baichoo N; Resnick J; Ye Z; McCormick W; Weir JP
Influenza Other Respir Viruses; 2016 Mar; 10(2):134-40. PubMed ID: 26616263
[TBL] [Abstract][Full Text] [Related]
6. An ELISA-based assay for determining haemagglutinin potency in egg, cell, or recombinant protein derived influenza vaccines.
Bodle J; Vandenberg K; Laurie K; Barr IG; Zhang Y; Rockman S
Front Immunol; 2023; 14():1147028. PubMed ID: 37033922
[TBL] [Abstract][Full Text] [Related]
7. Hemagglutinin Quantitative ELISA-based Potency Assay for Trivalent Seasonal Influenza Vaccine Using Group-Specific Universal Monoclonal Antibodies.
Chae W; Kim P; Kim H; Cheong YC; Kim YS; Kang SM; Seong BL
Sci Rep; 2019 Dec; 9(1):19675. PubMed ID: 31873147
[TBL] [Abstract][Full Text] [Related]
8. Universal monoclonal antibody-based influenza hemagglutinin quantitative enzyme-linked immunosorbent assay.
Chae W; Kim P; Hwang BJ; Seong BL
Vaccine; 2019 Mar; 37(11):1457-1466. PubMed ID: 30765169
[TBL] [Abstract][Full Text] [Related]
9. Determination of H5N1 vaccine potency using reference antisera from heterologous strains of influenza.
Vodeiko GM; Weir JP
Influenza Other Respir Viruses; 2012 May; 6(3):176-87. PubMed ID: 21902817
[TBL] [Abstract][Full Text] [Related]
10. Assessing the stability-indicating properties of alternative potency assays for inactivated influenza vaccine.
Ekimov A; Arunachalam AB; Blake T; Bodle J; Couzens L; Dubey S; Eichelberger M; Engelhardt OG; Gubinelli F; Joshi M; Melnyk D; Palladino G; Rigsby P; Rockman S; Savina N; Smith E; Gilchrist SAN;
Vaccine; 2023 Jul; 41(32):4639-4647. PubMed ID: 37344260
[TBL] [Abstract][Full Text] [Related]
11. Avian glycan-specific IgM monoclonal antibodies for the detection and quantitation of type A and B haemagglutinins in egg-derived influenza vaccines.
Legastelois I; Chevalier M; Bernard MC; de Montfort A; Fouque M; Pilloud A; Serraille C; Devard N; Engel O; Sodoyer R; Moste C
J Virol Methods; 2011 Dec; 178(1-2):129-36. PubMed ID: 21907241
[TBL] [Abstract][Full Text] [Related]
12. Rapid determination of influenza vaccine potency by an SPR-based method using subtype or lineage-specific monoclonal antibodies.
Narayan K; Paduraru C; Blake T; Arunachalam AB
Front Immunol; 2023; 14():1128683. PubMed ID: 37457687
[TBL] [Abstract][Full Text] [Related]
13. Application of deglycosylation and electrophoresis to the quantification of influenza viral hemagglutinins facilitating the production of 2009 pandemic influenza (H1N1) vaccines at multiple manufacturing sites in China.
Li C; Shao M; Cui X; Song Y; Li J; Yuan L; Fang H; Liang Z; Cyr TD; Li F; Li X; Wang J
Biologicals; 2010 Mar; 38(2):284-9. PubMed ID: 20074976
[TBL] [Abstract][Full Text] [Related]
14. Optimization and qualification of a quantitative reversed-phase HPLC method for hemagglutinin in influenza preparations and its comparative evaluation with biochemical assays.
Lorbetskie B; Wang J; Gravel C; Allen C; Walsh M; Rinfret A; Li X; Girard M
Vaccine; 2011 Apr; 29(18):3377-89. PubMed ID: 21397719
[TBL] [Abstract][Full Text] [Related]
15. Inactivated influenza vaccine stress can affect in vitro potency assay relationship to immunogenicity.
Wen Y; Palladino G; Xie Y; Ferrari A; Settembre EC
Vaccine; 2018 May; 36(21):3010-3017. PubMed ID: 29680201
[TBL] [Abstract][Full Text] [Related]
16. Development of an enzyme-linked immunoassay for the quantitation of influenza haemagglutinin: an alternative method to single radial immunodiffusion.
Bodle J; Verity EE; Ong C; Vandenberg K; Shaw R; Barr IG; Rockman S
Influenza Other Respir Viruses; 2013 Mar; 7(2):191-200. PubMed ID: 22583601
[TBL] [Abstract][Full Text] [Related]
17. Recombinant HA1 produced in E. coli forms functional oligomers and generates strain-specific SRID potency antibodies for pandemic influenza vaccines.
Khurana S; Larkin C; Verma S; Joshi MB; Fontana J; Steven AC; King LR; Manischewitz J; McCormick W; Gupta RK; Golding H
Vaccine; 2011 Aug; 29(34):5657-65. PubMed ID: 21704111
[TBL] [Abstract][Full Text] [Related]
18. Novel antibody-independent receptor-binding SPR-based assay for rapid measurement of influenza vaccine potency.
Khurana S; King LR; Manischewitz J; Coyle EM; Golding H
Vaccine; 2014 Apr; 32(19):2188-97. PubMed ID: 24613520
[TBL] [Abstract][Full Text] [Related]
19. A latex agglutination assay to quantify the amount of hemagglutinin protein in adjuvanted low-dose influenza monovalent vaccines.
Buffin S; Ikhelef N; Prudent J; Dubayle J; Nougarede N; Varenne MP; Moste C; Legastelois I
J Virol Methods; 2018 Jan; 251():46-53. PubMed ID: 29030070
[TBL] [Abstract][Full Text] [Related]
20. The differential effect of sub-micron level HA aggregates on influenza potency assays.
Lemieux M; Lorbetskie B; Luebbert CC; Walrond L; Li C; Li X; Cyr T; Sauvé S; Johnston MJW; Farnsworth A
Vaccine; 2019 Aug; 37(36):5276-5287. PubMed ID: 31337591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
